[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Non-opioid Pain Patch, Market Insights and Forecast to 2026

September 2020 | 113 pages | ID: C9DA471E9595EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Non-opioid Pain Patch market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Non-opioid Pain Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Non-opioid Pain Patch market is segmented into
  • Lidocaine Patches
  • Diclofenac Patches
  • Methyl Salicylate Patches
  • Capsaicin Patches
  • Ketoprofen Patches
  • Others
Segment by Application, the Non-opioid Pain Patch market is segmented into
  • Hospital Pharmacies
  • Online Pharmacies
  • Independent Pharmacies & Drug Stores
Regional and Country-level Analysis
The Non-opioid Pain Patch market is analysed and market size information is provided by regions (countries).

The key regions covered in the Non-opioid Pain Patch market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Non-opioid Pain Patch Market Share Analysis
Non-opioid Pain Patch market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Non-opioid Pain Patch business, the date to enter into the Non-opioid Pain Patch market, Non-opioid Pain Patch product introduction, recent developments, etc.

The major vendors covered:
  • Acorda Therapeutics
  • ALLERGAN
  • Endo International
  • GlaxoSmithKline
  • Hisamitsu Pharmaceutical
  • IBSA Institut Biochimque
  • Mylan
  • Pfizer
  • TEH SENG Pharmaceutical Mfg
  • Teikoku Seiyaku
1 STUDY COVERAGE

1.1 Non-opioid Pain Patch Product Introduction
1.2 Market Segments
1.3 Key Non-opioid Pain Patch Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
  1.4.1 Global Non-opioid Pain Patch Market Size Growth Rate by Type
  1.4.2 Lidocaine Patches
  1.4.3 Diclofenac Patches
  1.4.4 Methyl Salicylate Patches
  1.4.5 Capsaicin Patches
  1.4.6 Ketoprofen Patches
  1.4.7 Others
1.5 Market by Application
  1.5.1 Global Non-opioid Pain Patch Market Size Growth Rate by Application
  1.5.2 Hospital Pharmacies
  1.5.3 Online Pharmacies
  1.5.4 Independent Pharmacies & Drug Stores
1.6 Coronavirus Disease 2019 (Covid-19): Non-opioid Pain Patch Industry Impact
  1.6.1 How the Covid-19 is Affecting the Non-opioid Pain Patch Industry
    1.6.1.1 Non-opioid Pain Patch Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Non-opioid Pain Patch Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Non-opioid Pain Patch Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Non-opioid Pain Patch Market Size Estimates and Forecasts
  2.1.1 Global Non-opioid Pain Patch Revenue 2015-2026
  2.1.2 Global Non-opioid Pain Patch Sales 2015-2026
2.2 Non-opioid Pain Patch Market Size by Region: 2020 Versus 2026
  2.2.1 Global Non-opioid Pain Patch Retrospective Market Scenario in Sales by Region: 2015-2020
  2.2.2 Global Non-opioid Pain Patch Retrospective Market Scenario in Revenue by Region: 2015-2020

3 GLOBAL NON-OPIOID PAIN PATCH COMPETITOR LANDSCAPE BY PLAYERS

3.1 Non-opioid Pain Patch Sales by Manufacturers
  3.1.1 Non-opioid Pain Patch Sales by Manufacturers (2015-2020)
  3.1.2 Non-opioid Pain Patch Sales Market Share by Manufacturers (2015-2020)
3.2 Non-opioid Pain Patch Revenue by Manufacturers
  3.2.1 Non-opioid Pain Patch Revenue by Manufacturers (2015-2020)
  3.2.2 Non-opioid Pain Patch Revenue Share by Manufacturers (2015-2020)
  3.2.3 Global Non-opioid Pain Patch Market Concentration Ratio (CR5 and HHI) (2015-2020)
  3.2.4 Global Top 10 and Top 5 Companies by Non-opioid Pain Patch Revenue in 2019
  3.2.5 Global Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Non-opioid Pain Patch Price by Manufacturers
3.4 Non-opioid Pain Patch Manufacturing Base Distribution, Product Types
  3.4.1 Non-opioid Pain Patch Manufacturers Manufacturing Base Distribution, Headquarters
  3.4.2 Manufacturers Non-opioid Pain Patch Product Type
  3.4.3 Date of International Manufacturers Enter into Non-opioid Pain Patch Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Non-opioid Pain Patch Market Size by Type (2015-2020)
  4.1.1 Global Non-opioid Pain Patch Sales by Type (2015-2020)
  4.1.2 Global Non-opioid Pain Patch Revenue by Type (2015-2020)
  4.1.3 Non-opioid Pain Patch Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Non-opioid Pain Patch Market Size Forecast by Type (2021-2026)
  4.2.1 Global Non-opioid Pain Patch Sales Forecast by Type (2021-2026)
  4.2.2 Global Non-opioid Pain Patch Revenue Forecast by Type (2021-2026)
  4.2.3 Non-opioid Pain Patch Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Non-opioid Pain Patch Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Non-opioid Pain Patch Market Size by Application (2015-2020)
  5.1.1 Global Non-opioid Pain Patch Sales by Application (2015-2020)
  5.1.2 Global Non-opioid Pain Patch Revenue by Application (2015-2020)
  5.1.3 Non-opioid Pain Patch Price by Application (2015-2020)
5.2 Non-opioid Pain Patch Market Size Forecast by Application (2021-2026)
  5.2.1 Global Non-opioid Pain Patch Sales Forecast by Application (2021-2026)
  5.2.2 Global Non-opioid Pain Patch Revenue Forecast by Application (2021-2026)
  5.2.3 Global Non-opioid Pain Patch Price Forecast by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Non-opioid Pain Patch by Country
  6.1.1 North America Non-opioid Pain Patch Sales by Country
  6.1.2 North America Non-opioid Pain Patch Revenue by Country
  6.1.3 U.S.
  6.1.4 Canada
6.2 North America Non-opioid Pain Patch Market Facts & Figures by Type
6.3 North America Non-opioid Pain Patch Market Facts & Figures by Application

7 EUROPE

7.1 Europe Non-opioid Pain Patch by Country
  7.1.1 Europe Non-opioid Pain Patch Sales by Country
  7.1.2 Europe Non-opioid Pain Patch Revenue by Country
  7.1.3 Germany
  7.1.4 France
  7.1.5 U.K.
  7.1.6 Italy
  7.1.7 Russia
7.2 Europe Non-opioid Pain Patch Market Facts & Figures by Type
7.3 Europe Non-opioid Pain Patch Market Facts & Figures by Application

8 ASIA PACIFIC

8.1 Asia Pacific Non-opioid Pain Patch by Region
  8.1.1 Asia Pacific Non-opioid Pain Patch Sales by Region
  8.1.2 Asia Pacific Non-opioid Pain Patch Revenue by Region
  8.1.3 China
  8.1.4 Japan
  8.1.5 South Korea
  8.1.6 India
  8.1.7 Australia
  8.1.8 Taiwan
  8.1.9 Indonesia
  8.1.10 Thailand
  8.1.11 Malaysia
  8.1.12 Philippines
  8.1.13 Vietnam
8.2 Asia Pacific Non-opioid Pain Patch Market Facts & Figures by Type
8.3 Asia Pacific Non-opioid Pain Patch Market Facts & Figures by Application

9 LATIN AMERICA

9.1 Latin America Non-opioid Pain Patch by Country
  9.1.1 Latin America Non-opioid Pain Patch Sales by Country
  9.1.2 Latin America Non-opioid Pain Patch Revenue by Country
  9.1.3 Mexico
  9.1.4 Brazil
  9.1.5 Argentina
9.2 Central & South America Non-opioid Pain Patch Market Facts & Figures by Type
9.3 Central & South America Non-opioid Pain Patch Market Facts & Figures by Application

10 MIDDLE EAST AND AFRICA

10.1 Middle East and Africa Non-opioid Pain Patch by Country
  10.1.1 Middle East and Africa Non-opioid Pain Patch Sales by Country
  10.1.2 Middle East and Africa Non-opioid Pain Patch Revenue by Country
  10.1.3 Turkey
  10.1.4 Saudi Arabia
  10.1.5 U.A.E
10.2 Middle East and Africa Non-opioid Pain Patch Market Facts & Figures by Type
10.3 Middle East and Africa Non-opioid Pain Patch Market Facts & Figures by Application

11 COMPANY PROFILES

11.1 Acorda Therapeutics
  11.1.1 Acorda Therapeutics Corporation Information
  11.1.2 Acorda Therapeutics Description, Business Overview and Total Revenue
  11.1.3 Acorda Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Acorda Therapeutics Non-opioid Pain Patch Products Offered
  11.1.5 Acorda Therapeutics Recent Development
11.2 ALLERGAN
  11.2.1 ALLERGAN Corporation Information
  11.2.2 ALLERGAN Description, Business Overview and Total Revenue
  11.2.3 ALLERGAN Sales, Revenue and Gross Margin (2015-2020)
  11.2.4 ALLERGAN Non-opioid Pain Patch Products Offered
  11.2.5 ALLERGAN Recent Development
11.3 Endo International
  11.3.1 Endo International Corporation Information
  11.3.2 Endo International Description, Business Overview and Total Revenue
  11.3.3 Endo International Sales, Revenue and Gross Margin (2015-2020)
  11.3.4 Endo International Non-opioid Pain Patch Products Offered
  11.3.5 Endo International Recent Development
11.4 GlaxoSmithKline
  11.4.1 GlaxoSmithKline Corporation Information
  11.4.2 GlaxoSmithKline Description, Business Overview and Total Revenue
  11.4.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
  11.4.4 GlaxoSmithKline Non-opioid Pain Patch Products Offered
  11.4.5 GlaxoSmithKline Recent Development
11.5 Hisamitsu Pharmaceutical
  11.5.1 Hisamitsu Pharmaceutical Corporation Information
  11.5.2 Hisamitsu Pharmaceutical Description, Business Overview and Total Revenue
  11.5.3 Hisamitsu Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
  11.5.4 Hisamitsu Pharmaceutical Non-opioid Pain Patch Products Offered
  11.5.5 Hisamitsu Pharmaceutical Recent Development
11.6 IBSA Institut Biochimque
  11.6.1 IBSA Institut Biochimque Corporation Information
  11.6.2 IBSA Institut Biochimque Description, Business Overview and Total Revenue
  11.6.3 IBSA Institut Biochimque Sales, Revenue and Gross Margin (2015-2020)
  11.6.4 IBSA Institut Biochimque Non-opioid Pain Patch Products Offered
  11.6.5 IBSA Institut Biochimque Recent Development
11.7 Mylan
  11.7.1 Mylan Corporation Information
  11.7.2 Mylan Description, Business Overview and Total Revenue
  11.7.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
  11.7.4 Mylan Non-opioid Pain Patch Products Offered
  11.7.5 Mylan Recent Development
11.8 Pfizer
  11.8.1 Pfizer Corporation Information
  11.8.2 Pfizer Description, Business Overview and Total Revenue
  11.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
  11.8.4 Pfizer Non-opioid Pain Patch Products Offered
  11.8.5 Pfizer Recent Development
11.9 TEH SENG Pharmaceutical Mfg
  11.9.1 TEH SENG Pharmaceutical Mfg Corporation Information
  11.9.2 TEH SENG Pharmaceutical Mfg Description, Business Overview and Total Revenue
  11.9.3 TEH SENG Pharmaceutical Mfg Sales, Revenue and Gross Margin (2015-2020)
  11.9.4 TEH SENG Pharmaceutical Mfg Non-opioid Pain Patch Products Offered
  11.9.5 TEH SENG Pharmaceutical Mfg Recent Development
11.10 Teikoku Seiyaku
  11.10.1 Teikoku Seiyaku Corporation Information
  11.10.2 Teikoku Seiyaku Description, Business Overview and Total Revenue
  11.10.3 Teikoku Seiyaku Sales, Revenue and Gross Margin (2015-2020)
  11.10.4 Teikoku Seiyaku Non-opioid Pain Patch Products Offered
  11.10.5 Teikoku Seiyaku Recent Development
11.1 Acorda Therapeutics
  11.1.1 Acorda Therapeutics Corporation Information
  11.1.2 Acorda Therapeutics Description, Business Overview and Total Revenue
  11.1.3 Acorda Therapeutics Sales, Revenue and Gross Margin (2015-2020)
  11.1.4 Acorda Therapeutics Non-opioid Pain Patch Products Offered
  11.1.5 Acorda Therapeutics Recent Development

12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)

12.1 Non-opioid Pain Patch Market Estimates and Projections by Region
  12.1.1 Global Non-opioid Pain Patch Sales Forecast by Regions 2021-2026
  12.1.2 Global Non-opioid Pain Patch Revenue Forecast by Regions 2021-2026
12.2 North America Non-opioid Pain Patch Market Size Forecast (2021-2026)
  12.2.1 North America: Non-opioid Pain Patch Sales Forecast (2021-2026)
  12.2.2 North America: Non-opioid Pain Patch Revenue Forecast (2021-2026)
  12.2.3 North America: Non-opioid Pain Patch Market Size Forecast by Country (2021-2026)
12.3 Europe Non-opioid Pain Patch Market Size Forecast (2021-2026)
  12.3.1 Europe: Non-opioid Pain Patch Sales Forecast (2021-2026)
  12.3.2 Europe: Non-opioid Pain Patch Revenue Forecast (2021-2026)
  12.3.3 Europe: Non-opioid Pain Patch Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Non-opioid Pain Patch Market Size Forecast (2021-2026)
  12.4.1 Asia Pacific: Non-opioid Pain Patch Sales Forecast (2021-2026)
  12.4.2 Asia Pacific: Non-opioid Pain Patch Revenue Forecast (2021-2026)
  12.4.3 Asia Pacific: Non-opioid Pain Patch Market Size Forecast by Region (2021-2026)
12.5 Latin America Non-opioid Pain Patch Market Size Forecast (2021-2026)
  12.5.1 Latin America: Non-opioid Pain Patch Sales Forecast (2021-2026)
  12.5.2 Latin America: Non-opioid Pain Patch Revenue Forecast (2021-2026)
  12.5.3 Latin America: Non-opioid Pain Patch Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Non-opioid Pain Patch Market Size Forecast (2021-2026)
  12.6.1 Middle East and Africa: Non-opioid Pain Patch Sales Forecast (2021-2026)
  12.6.2 Middle East and Africa: Non-opioid Pain Patch Revenue Forecast (2021-2026)
  12.6.3 Middle East and Africa: Non-opioid Pain Patch Market Size Forecast by Country (2021-2026)

13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS

13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Non-opioid Pain Patch Players (Opinion Leaders)

14 VALUE CHAIN AND SALES CHANNELS ANALYSIS

14.1 Value Chain Analysis
14.2 Non-opioid Pain Patch Customers
14.3 Sales Channels Analysis
  14.3.1 Sales Channels
  14.3.2 Distributors

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Research Methodology
  16.1.1 Methodology/Research Approach
  16.1.2 Data Source
16.2 Author Details
LIST OF TABLES

Table 1. Non-opioid Pain Patch Market Segments
Table 2. Ranking of Global Top Non-opioid Pain Patch Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Non-opioid Pain Patch Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Lidocaine Patches
Table 5. Major Manufacturers of Diclofenac Patches
Table 6. Major Manufacturers of Methyl Salicylate Patches
Table 7. Major Manufacturers of Capsaicin Patches
Table 8. Major Manufacturers of Ketoprofen Patches
Table 9. Major Manufacturers of Others
Table 10. COVID-19 Impact Global Market: (Four Non-opioid Pain Patch Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Non-opioid Pain Patch Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Non-opioid Pain Patch Players to Combat Covid-19 Impact
Table 15. Global Non-opioid Pain Patch Market Size Growth Rate by Application 2020-2026 (K MT)
Table 16. Global Non-opioid Pain Patch Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 17. Global Non-opioid Pain Patch Sales by Regions 2015-2020 (K MT)
Table 18. Global Non-opioid Pain Patch Sales Market Share by Regions (2015-2020)
Table 19. Global Non-opioid Pain Patch Revenue by Regions 2015-2020 (US$ Million)
Table 20. Global Non-opioid Pain Patch Sales by Manufacturers (2015-2020) (K MT)
Table 21. Global Non-opioid Pain Patch Sales Share by Manufacturers (2015-2020)
Table 22. Global Non-opioid Pain Patch Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 23. Global Non-opioid Pain Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-opioid Pain Patch as of 2019)
Table 24. Non-opioid Pain Patch Revenue by Manufacturers (2015-2020) (US$ Million)
Table 25. Non-opioid Pain Patch Revenue Share by Manufacturers (2015-2020)
Table 26. Key Manufacturers Non-opioid Pain Patch Price (2015-2020) (USD/MT)
Table 27. Non-opioid Pain Patch Manufacturers Manufacturing Base Distribution and Headquarters
Table 28. Manufacturers Non-opioid Pain Patch Product Type
Table 29. Date of International Manufacturers Enter into Non-opioid Pain Patch Market
Table 30. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 31. Global Non-opioid Pain Patch Sales by Type (2015-2020) (K MT)
Table 32. Global Non-opioid Pain Patch Sales Share by Type (2015-2020)
Table 33. Global Non-opioid Pain Patch Revenue by Type (2015-2020) (US$ Million)
Table 34. Global Non-opioid Pain Patch Revenue Share by Type (2015-2020)
Table 35. Non-opioid Pain Patch Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 36. Global Non-opioid Pain Patch Sales by Application (2015-2020) (K MT)
Table 37. Global Non-opioid Pain Patch Sales Share by Application (2015-2020)
Table 38. North America Non-opioid Pain Patch Sales by Country (2015-2020) (K MT)
Table 39. North America Non-opioid Pain Patch Sales Market Share by Country (2015-2020)
Table 40. North America Non-opioid Pain Patch Revenue by Country (2015-2020) (US$ Million)
Table 41. North America Non-opioid Pain Patch Revenue Market Share by Country (2015-2020)
Table 42. North America Non-opioid Pain Patch Sales by Type (2015-2020) (K MT)
Table 43. North America Non-opioid Pain Patch Sales Market Share by Type (2015-2020)
Table 44. North America Non-opioid Pain Patch Sales by Application (2015-2020) (K MT)
Table 45. North America Non-opioid Pain Patch Sales Market Share by Application (2015-2020)
Table 46. Europe Non-opioid Pain Patch Sales by Country (2015-2020) (K MT)
Table 47. Europe Non-opioid Pain Patch Sales Market Share by Country (2015-2020)
Table 48. Europe Non-opioid Pain Patch Revenue by Country (2015-2020) (US$ Million)
Table 49. Europe Non-opioid Pain Patch Revenue Market Share by Country (2015-2020)
Table 50. Europe Non-opioid Pain Patch Sales by Type (2015-2020) (K MT)
Table 51. Europe Non-opioid Pain Patch Sales Market Share by Type (2015-2020)
Table 52. Europe Non-opioid Pain Patch Sales by Application (2015-2020) (K MT)
Table 53. Europe Non-opioid Pain Patch Sales Market Share by Application (2015-2020)
Table 54. Asia Pacific Non-opioid Pain Patch Sales by Region (2015-2020) (K MT)
Table 55. Asia Pacific Non-opioid Pain Patch Sales Market Share by Region (2015-2020)
Table 56. Asia Pacific Non-opioid Pain Patch Revenue by Region (2015-2020) (US$ Million)
Table 57. Asia Pacific Non-opioid Pain Patch Revenue Market Share by Region (2015-2020)
Table 58. Asia Pacific Non-opioid Pain Patch Sales by Type (2015-2020) (K MT)
Table 59. Asia Pacific Non-opioid Pain Patch Sales Market Share by Type (2015-2020)
Table 60. Asia Pacific Non-opioid Pain Patch Sales by Application (2015-2020) (K MT)
Table 61. Asia Pacific Non-opioid Pain Patch Sales Market Share by Application (2015-2020)
Table 62. Latin America Non-opioid Pain Patch Sales by Country (2015-2020) (K MT)
Table 63. Latin America Non-opioid Pain Patch Sales Market Share by Country (2015-2020)
Table 64. Latin Americaa Non-opioid Pain Patch Revenue by Country (2015-2020) (US$ Million)
Table 65. Latin America Non-opioid Pain Patch Revenue Market Share by Country (2015-2020)
Table 66. Latin America Non-opioid Pain Patch Sales by Type (2015-2020) (K MT)
Table 67. Latin America Non-opioid Pain Patch Sales Market Share by Type (2015-2020)
Table 68. Latin America Non-opioid Pain Patch Sales by Application (2015-2020) (K MT)
Table 69. Latin America Non-opioid Pain Patch Sales Market Share by Application (2015-2020)
Table 70. Middle East and Africa Non-opioid Pain Patch Sales by Country (2015-2020) (K MT)
Table 71. Middle East and Africa Non-opioid Pain Patch Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Non-opioid Pain Patch Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Non-opioid Pain Patch Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Non-opioid Pain Patch Sales by Type (2015-2020) (K MT)
Table 75. Middle East and Africa Non-opioid Pain Patch Sales Market Share by Type (2015-2020)
Table 76. Middle East and Africa Non-opioid Pain Patch Sales by Application (2015-2020) (K MT)
Table 77. Middle East and Africa Non-opioid Pain Patch Sales Market Share by Application (2015-2020)
Table 78. Acorda Therapeutics Corporation Information
Table 79. Acorda Therapeutics Description and Major Businesses
Table 80. Acorda Therapeutics Non-opioid Pain Patch Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Acorda Therapeutics Product
Table 82. Acorda Therapeutics Recent Development
Table 83. ALLERGAN Corporation Information
Table 84. ALLERGAN Description and Major Businesses
Table 85. ALLERGAN Non-opioid Pain Patch Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. ALLERGAN Product
Table 87. ALLERGAN Recent Development
Table 88. Endo International Corporation Information
Table 89. Endo International Description and Major Businesses
Table 90. Endo International Non-opioid Pain Patch Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Endo International Product
Table 92. Endo International Recent Development
Table 93. GlaxoSmithKline Corporation Information
Table 94. GlaxoSmithKline Description and Major Businesses
Table 95. GlaxoSmithKline Non-opioid Pain Patch Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. GlaxoSmithKline Product
Table 97. GlaxoSmithKline Recent Development
Table 98. Hisamitsu Pharmaceutical Corporation Information
Table 99. Hisamitsu Pharmaceutical Description and Major Businesses
Table 100. Hisamitsu Pharmaceutical Non-opioid Pain Patch Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Hisamitsu Pharmaceutical Product
Table 102. Hisamitsu Pharmaceutical Recent Development
Table 103. IBSA Institut Biochimque Corporation Information
Table 104. IBSA Institut Biochimque Description and Major Businesses
Table 105. IBSA Institut Biochimque Non-opioid Pain Patch Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. IBSA Institut Biochimque Product
Table 107. IBSA Institut Biochimque Recent Development
Table 108. Mylan Corporation Information
Table 109. Mylan Description and Major Businesses
Table 110. Mylan Non-opioid Pain Patch Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Mylan Product
Table 112. Mylan Recent Development
Table 113. Pfizer Corporation Information
Table 114. Pfizer Description and Major Businesses
Table 115. Pfizer Non-opioid Pain Patch Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. Pfizer Product
Table 117. Pfizer Recent Development
Table 118. TEH SENG Pharmaceutical Mfg Corporation Information
Table 119. TEH SENG Pharmaceutical Mfg Description and Major Businesses
Table 120. TEH SENG Pharmaceutical Mfg Non-opioid Pain Patch Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. TEH SENG Pharmaceutical Mfg Product
Table 122. TEH SENG Pharmaceutical Mfg Recent Development
Table 123. Teikoku Seiyaku Corporation Information
Table 124. Teikoku Seiyaku Description and Major Businesses
Table 125. Teikoku Seiyaku Non-opioid Pain Patch Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 126. Teikoku Seiyaku Product
Table 127. Teikoku Seiyaku Recent Development
Table 128. Global Non-opioid Pain Patch Sales Forecast by Regions (2021-2026) (K MT)
Table 129. Global Non-opioid Pain Patch Sales Market Share Forecast by Regions (2021-2026)
Table 130. Global Non-opioid Pain Patch Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 131. Global Non-opioid Pain Patch Revenue Market Share Forecast by Regions (2021-2026)
Table 132. North America: Non-opioid Pain Patch Sales Forecast by Country (2021-2026) (K MT)
Table 133. North America: Non-opioid Pain Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Europe: Non-opioid Pain Patch Sales Forecast by Country (2021-2026) (K MT)
Table 135. Europe: Non-opioid Pain Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Asia Pacific: Non-opioid Pain Patch Sales Forecast by Region (2021-2026) (K MT)
Table 137. Asia Pacific: Non-opioid Pain Patch Revenue Forecast by Region (2021-2026) (US$ Million)
Table 138. Latin America: Non-opioid Pain Patch Sales Forecast by Country (2021-2026) (K MT)
Table 139. Latin America: Non-opioid Pain Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Middle East and Africa: Non-opioid Pain Patch Sales Forecast by Country (2021-2026) (K MT)
Table 141. Middle East and Africa: Non-opioid Pain Patch Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 143. Key Challenges
Table 144. Market Risks
Table 145. Main Points Interviewed from Key Non-opioid Pain Patch Players
Table 146. Non-opioid Pain Patch Customers List
Table 147. Non-opioid Pain Patch Distributors List
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Non-opioid Pain Patch Product Picture
Figure 2. Global Non-opioid Pain Patch Sales Market Share by Type in 2020 & 2026
Figure 3. Lidocaine Patches Product Picture
Figure 4. Diclofenac Patches Product Picture
Figure 5. Methyl Salicylate Patches Product Picture
Figure 6. Capsaicin Patches Product Picture
Figure 7. Ketoprofen Patches Product Picture
Figure 8. Others Product Picture
Figure 9. Global Non-opioid Pain Patch Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital Pharmacies
Figure 11. Online Pharmacies
Figure 12. Independent Pharmacies & Drug Stores
Figure 13. Non-opioid Pain Patch Report Years Considered
Figure 14. Global Non-opioid Pain Patch Market Size 2015-2026 (US$ Million)
Figure 15. Global Non-opioid Pain Patch Sales 2015-2026 (K MT)
Figure 16. Global Non-opioid Pain Patch Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Non-opioid Pain Patch Sales Market Share by Region (2015-2020)
Figure 18. Global Non-opioid Pain Patch Sales Market Share by Region in 2019
Figure 19. Global Non-opioid Pain Patch Revenue Market Share by Region (2015-2020)
Figure 20. Global Non-opioid Pain Patch Revenue Market Share by Region in 2019
Figure 21. Global Non-opioid Pain Patch Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Non-opioid Pain Patch Revenue in 2019
Figure 23. Non-opioid Pain Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Non-opioid Pain Patch Sales Market Share by Type (2015-2020)
Figure 25. Global Non-opioid Pain Patch Sales Market Share by Type in 2019
Figure 26. Global Non-opioid Pain Patch Revenue Market Share by Type (2015-2020)
Figure 27. Global Non-opioid Pain Patch Revenue Market Share by Type in 2019
Figure 28. Global Non-opioid Pain Patch Market Share by Price Range (2015-2020)
Figure 29. Global Non-opioid Pain Patch Sales Market Share by Application (2015-2020)
Figure 30. Global Non-opioid Pain Patch Sales Market Share by Application in 2019
Figure 31. Global Non-opioid Pain Patch Revenue Market Share by Application (2015-2020)
Figure 32. Global Non-opioid Pain Patch Revenue Market Share by Application in 2019
Figure 33. North America Non-opioid Pain Patch Sales Growth Rate 2015-2020 (K MT)
Figure 34. North America Non-opioid Pain Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Non-opioid Pain Patch Sales Market Share by Country in 2019
Figure 36. North America Non-opioid Pain Patch Revenue Market Share by Country in 2019
Figure 37. U.S. Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 38. U.S. Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 40. Canada Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Non-opioid Pain Patch Market Share by Type in 2019
Figure 42. North America Non-opioid Pain Patch Market Share by Application in 2019
Figure 43. Europe Non-opioid Pain Patch Sales Growth Rate 2015-2020 (K MT)
Figure 44. Europe Non-opioid Pain Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Non-opioid Pain Patch Sales Market Share by Country in 2019
Figure 46. Europe Non-opioid Pain Patch Revenue Market Share by Country in 2019
Figure 47. Germany Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 48. Germany Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 50. France Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 52. U.K. Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 54. Italy Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 56. Russia Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Non-opioid Pain Patch Market Share by Type in 2019
Figure 58. Europe Non-opioid Pain Patch Market Share by Application in 2019
Figure 59. Asia Pacific Non-opioid Pain Patch Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Non-opioid Pain Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Non-opioid Pain Patch Sales Market Share by Region in 2019
Figure 62. Asia Pacific Non-opioid Pain Patch Revenue Market Share by Region in 2019
Figure 63. China Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Non-opioid Pain Patch Market Share by Type in 2019
Figure 86. Asia Pacific Non-opioid Pain Patch Market Share by Application in 2019
Figure 87. Latin America Non-opioid Pain Patch Sales Growth Rate 2015-2020 (K MT)
Figure 88. Latin America Non-opioid Pain Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Non-opioid Pain Patch Sales Market Share by Country in 2019
Figure 90. Latin America Non-opioid Pain Patch Revenue Market Share by Country in 2019
Figure 91. Mexico Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 92. Mexico Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 94. Brazil Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 96. Argentina Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Non-opioid Pain Patch Market Share by Type in 2019
Figure 98. Latin America Non-opioid Pain Patch Market Share by Application in 2019
Figure 99. Middle East and Africa Non-opioid Pain Patch Sales Growth Rate 2015-2020 (K MT)
Figure 100. Middle East and Africa Non-opioid Pain Patch Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Non-opioid Pain Patch Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Non-opioid Pain Patch Revenue Market Share by Country in 2019
Figure 103. Turkey Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 104. Turkey Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 106. Saudi Arabia Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Non-opioid Pain Patch Sales Growth Rate (2015-2020) (K MT)
Figure 108. U.A.E Non-opioid Pain Patch Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Non-opioid Pain Patch Market Share by Type in 2019
Figure 110. Middle East and Africa Non-opioid Pain Patch Market Share by Application in 2019
Figure 111. Acorda Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. ALLERGAN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Endo International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Hisamitsu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. IBSA Institut Biochimque Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. TEH SENG Pharmaceutical Mfg Total Revenue (US$ Million): 2019 Compared with 2018
Figure 120. Teikoku Seiyaku Total Revenue (US$ Million): 2019 Compared with 2018
Figure 121. North America Non-opioid Pain Patch Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. North America Non-opioid Pain Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Europe Non-opioid Pain Patch Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Europe Non-opioid Pain Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Asia Pacific Non-opioid Pain Patch Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Asia Pacific Non-opioid Pain Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Latin America Non-opioid Pain Patch Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Latin America Non-opioid Pain Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Middle East and Africa Non-opioid Pain Patch Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 130. Middle East and Africa Non-opioid Pain Patch Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 131. Porter's Five Forces Analysis
Figure 132. Channels of Distribution
Figure 133. Distributors Profiles
Figure 134. Bottom-up and Top-down Approaches for This Report
Figure 135. Data Triangulation
Figure 136. Key Executives Interviewed


More Publications